Psychedelic Assisted Therapy Interdisciplinary Insights for Care of the Seriously Ill

December 7, 2023

This event is a unique opportunity to delve into the latest advancements in psychedelic therapies and the intersections of palliative care. Our expert panel will provide valuable insights, share their experiences, and engage in thought-provoking conversations about this evolving field. Join us as we explore the forefront of psychedelic research and its transformative potential in serious illness care. Clinical trials using psilocybin and MDMA assisted psychotherapy models for people with Cancer Related Anxiety, Depression, and Existential Distress, as well as a number of general mental health indications, have shown promising, arguably, exciting results in a collection of Phase II and Phase III trials such that DEA rescheduling and FDA approval are expected as soon as 2024. In addition, off-label use of ketamine (at psychedelic doses) with therapy have proliferated for a variety of indications including in the palliative care and end of life domains. Learners will self-report increased knowledge for future practice application surrounding the current progress in the therapeutic models of psychedelic-assisted therapies in Palliative and Hospice Care.

Target Audience

Hospice Medical Directors
HPM Physicians
Nurses
Nurse Practitioners
Pharmacists
PAs

Activity summary
Available credit: 
  • 1.00 ABIM MOC
  • 1.00 ABS MOC
  • 1.00 CME (physician only)
  • 1.00 Participation
Activity Published: 
11/06/2023
Activity Expires: 
12/31/2023
Event starts: 
12/07/2023 - 11:00am CST
Event ends: 
12/07/2023 - 12:00pm CST
Member cost:
$39.00
List Price:
$49.00
Add to calendar: 
Rating: 
0

Disclosures 
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.

All editors, faculty and staff have disclosed no relevant financial relationships.

*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients. 

Faculty
Elisha Waldman, MD FAAHPM
Heather Lee, LCSW
Jamie Beachy, MDiv PhD
Rohini Kanniganti, MD MSPH HMDC
Yvan Beaussant, MD MSc

Staff
Leah Farfan, BA
Julie Tanner, BSN RN-BC CHPN
Liz Watson, BA
Angie Tryfonopoulos, BS
Theresa Nissen, BA
Laura Witt, MS-HSM
Julie Bruno, MSW LCSW

Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Hospice and Palliative Medicine (AAHPM) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion includes attesting to meaningful activity participation and completion/submission of activity evaluation within the time frame designated.

Evaluation period closes December 31, 2023 at 11:59pm CT for claiming CME credit.

Maintenance of Certification (MOC) Recognition Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Psychedelic Assisted Therapy Interdisciplinary Insights for Care of the Seriously Ill (apply toward general CME requirement) for the following ABMS Member Boards:
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit. By submitting your evaluation, you grant AAHPM permission to submit completion information to ACCME for the purpose of granting respective BOARD MOC program credit or points as applicable.

Evaluation period closes December 31, 2023 at 11:59pm CT for claiming MOC credits.
 

Available Credit

  • 1.00 ABIM MOC
  • 1.00 ABS MOC
  • 1.00 CME (physician only)
  • 1.00 Participation

Price

Member cost:
$39.00
List Price:
$49.00
Please login or register to take this course.